The potential therapeutic value of CDK6 inhibitors in critical COVID-19

[News]

While drug repurposing has been explored in the context of the current coronavirus disease 2019 (COVID-19) pandemic, the success of this strategy has been limited so far. A new study, released as a preprint on the medRxiv* server, describes a new method of identifying a promising hit among drugs already in use.

More... (https://www.news-medical.net/news/20210524/The-potential-therapeutic-value-of-CDK6-inhibitors-in-critical-COVID-19.aspx)